Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients

Hepato-Gastroenterology

Volumn 58, Issue 112, 2011, Pages 2007-2011

  Zheng, Yun ^a   Zhang, Youwei ^b   Huang, Xiang ^b   Chen, Longbang ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Biomarker; Circulating DNA; Colorectal cancer; Esophageal squamous cell carcinoma; Gastric cancer; Methylation; RUNX3

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; TRANSCRIPTION FACTOR RUNX3;

ADULT; ARTICLE; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ASSOCIATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84863230017     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10016     Document Type: Article

References (38)

1. Peto J: Cancer epidemiology in the last century and the next decade. Nature 2001; 411:390-395.
2. Paluszczak J, Baer-Dubowska W: Epigenetic diagnostics of cancer-the application of DNA methylation markers. J Appl Genet 2006; 47:365-375. (Pubitemid 44893733)
3. Huang Z, Li L, Wang J: Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci 2007; 52:2287-2291. (Pubitemid 47246528)
4. Ibanez de Caceres I, Battagli C, et al.: Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res 2004; 64:6476-6481. (Pubitemid 39297903)
5. Ito Y, Miyazono K: RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 2003; 13:43-47. (Pubitemid 36143926)
6. Guo WH, Weng LQ, Ito K, et al.: Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 2002; 21:8351-8355. (Pubitemid 35477876)
7. Li X, Zhang Y, Zhang Y, et al.: RUNX3 inhibits growth of HCC cells and HCC xenografts in mice in combination with adriamycin. Cancer Biol Ther 2008; 7:669-676.
8. Nagahama Y, Ishimaru M, Osaki M, et al.: Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1. Cancer Sci 2008; 99:23-30. (Pubitemid 350239027)
9. Tong DD, Jiang Y, Li M, et al.: RUNX3 inhibits cell proliferation and induces apoptosis by TGF-beta -dependent and -independent mechanisms in human colon carcinoma cells. Pathobiology 2009; 76:163-169.
10. Li QL, Ito K, Sakakura C, et al.: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109:113-124. (Pubitemid 34327521)
11. Ku JL, Kang SB, Shin YK, et al.: Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004; 23:6736-6742.
12. Oshimo Y, Oue N, Mitani Y, et al.: Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 2004; 71:137-143. (Pubitemid 38437708)
13. Kim TY, Lee HJ, Hwang KS, et al.: Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 2004; 84:479-484. (Pubitemid 41656475)
14. Wada M, Yazumi S, Takaishi S, et al.: Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 2004; 23:2401-2407. (Pubitemid 38496795)
15. Long C, Yin B, Lu Q, et al.: Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Cancer Invest 2007; 25:685-690. (Pubitemid 350223164)
16. Tonomoto Y, Tachibana M, Dhar DK, et al.: Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis. Oncology 2007; 73:346-356. (Pubitemid 351862027)
17. Hsu PI, Hsieh HL, Lee J, et al.: Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Ann Surg Oncol 2009; 16:1686-1694.
18. Soong R, Shah N, Peh BK, et al.: The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome. Br J Cancer 2009; 100:676-679.
19. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epitheHa. Cancer Sci 2003; 94:360-364. (Pubitemid 36626369)
20. Kim HC, Roh SA, Ga IH, Kim JS, Yu CS, Kim JC: CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 2005; 20:1920-1926. (Pubitemid 43961051)
21. Chi XZ, Yang JO, Lee KY, et al.: RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 2005; 25:8097-8107.
22. Wei D, Gong W, Oh SC, et al.: Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 2005; 65:4809-4816. (Pubitemid 40740819)
23. Peng Z, Tang H, Wang X, et al.: Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells. Int J Oncol 2008; 33:979-984.
24. Torquati A, O'rear L, Longobardi L, Spagnoli A, Richards WO, Beauchamp RD: RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. Surgery 2004; 136:310-316. (Pubitemid 39037670)
25. Sakakura C, Miyagawa K, Fukuda KI, et al.: Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 2007; 26:5927-5938.
26. Goel A, Arnold CN, Tassone P, et al.: Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 2004; 112:754-759. (Pubitemid 39435259)
27. Gao N, Chen WC, Cen JN: Relationship between Runx3 gene expression and its DNA methylation in gastric cancer. Zhonghua Zhong Liu Za Zhi 2008; 30:361-364.
28. Park WS, Cho YG, Kim CJ, et al.: Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp MoI Med 2005; 37:276-281. (Pubitemid 41330037)
29. Nomoto S, Kinoshita T, Mori T, et al.: Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer. Br J Cancer 2008; 98:1690-1695. (Pubitemid 351684677)
30. Smith E, De Young NJ, Pavey SJ, et al.: Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Mol Cancer 2008; 7:75.
31. Subramaniam MM, Chan JY, Soong R, et al.: RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis. Am J Gastroenterol 2009; 104:426-436.
32. Jahr S, Hentze H, Englisch S, et al.: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61:1659-1665. (Pubitemid 34292602)
33. Leung WK, To KF, Man EP, et al.: Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 2005; 100:2274-2279.
34. Ikoma D, Ichikawa D, Ueda Y, et al.: Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer. Anticancer Res 2007; 27:535-539. (Pubitemid 46374973)
35. Wang YC, Yu ZH, Liu C, et al.: Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 2008; 14:3074-3080.
36. Hiramatsu T, Osaki M, Ito Y, Tanji Y, Tokuyasu N, Ito H: Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma. Pathobiology 2005; 72:316-324.
37. Koike H, Ichikawa D, Ikoma H, et al.: Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepato-gastroenterology 2005; 52:1293-1296. (Pubitemid 40942233)
38. Sakakura C, Hamada T, Miyagawa K, et al.: Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Anticancer Res 2009; 29:2619-2625.